Re: Jest info

Leonard Osser, Interim Chief Executive Officer of Milestone Scientific, commented, "This study is another validation that the CompuFlo epidural instrument is a safe, proven alternative to the loss of resistance technique being used by most medical professionals. Loss of resistance is subjective and consequently associated with failure rates and accidental dural punctures that require further treatment and interventions such as epidural blood patches. The fact that none of the 812 patients who received epidural analgesia with CompuFlo® had an accidental dural puncture is a testament that our technology is effective in accurately identifying the epidural space. We are honored to have the results of this trial presented by Professor Rovnat Babazade at ANESTHESIOLOGY 2019 in front of world leaders in the field of anesthesia."

Idą z rozmysłem - teraz na szczycie anestezjologów w USA takie info to skarb. I to nie oni wszak będą to w poniedziałek przedstawiac tylko zacny profesor.
Jestem ciekaw jak to wpłynie na dzisiejsze notowania za Oceanem - notowania u nas - przy takich obrotach- na razie są kompletnie bez znaczenia. Jak właścicela zmienic 20-30 tys akcji - będzie można coś powiedzieć